We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
JELD-WEN Holding
JELD
$103M
| $82.6K | ﹤0.01% |
66,623
-12,410
| -16% | -$27.1K |
|
1052
Wave Life Sciences
WVE
$1.11B
| $75.5K | ﹤0.01% |
10,420
-1,137
| -10% | -$14.8K |
|
1053
Aquestive Therapeutics
AQST
$507M
| $61.9K | ﹤0.01% |
14,919
-10,507
| -41% | -$42.6K |
|
1054
ARKO Corp
ARKO
$890M
| $57.1K | ﹤0.01% |
+10,270
| New | +$57.3K |
|
|
KEEL
1055
Keel Infrastructure Corp
KEEL
$2.81B
| $43.6K | ﹤0.01% |
22,373
-3,415
| -13% | -$8.02K |
|
1056
Bit Digital
BTBT
$558M
| $15.9K | ﹤0.01% |
12,111
-2,890
| -19% | -$5.31K |
|
1057
Genco Shipping & Trading
GNK
$1.11B
| $13.6K | ﹤0.01% |
605
-58
| -9% | -$1.24K |
|
1058
Aecom
ACM
$8.86B
| – | – |
-2,226
| Closed | -$212K |
|
1059
C3.ai
AI
$1.34B
| – | – |
-10,419
| Closed | -$140K |
|
1060
Ally Financial
ALLY
$13.6B
| – | – |
-4,711
| Closed | -$213K |
|
1061
Ambarella
AMBA
$3.13B
| – | – |
-3,310
| Closed | -$234K |
|
1062
Amylyx Pharmaceuticals
AMLX
$2.06B
| – | – |
-17,673
| Closed | -$213K |
|
1063
Amphastar Pharmaceuticals
AMPH
$864M
| – | – |
-7,682
| Closed | -$206K |
|
1064
ANI Pharmaceuticals
ANIP
$1.8B
| – | – |
-2,851
| Closed | -$225K |
|
1065
Applied Digital
APLD
$8.59B
| – | – |
-8,912
| Closed | -$219K |
|
1066
Arvinas
ARVN
$533M
| – | – |
-17,650
| Closed | -$209K |
|
|
AVDL
1067
DELISTED
Avadel Pharmaceuticals
AVDL
| – | – |
-10,884
| Closed | -$235K |
|
1068
Avantor
AVTR
$7.5B
| – | – |
-11,458
| Closed | -$131K |
|
1069
Axsome Therapeutics
AXSM
$12.2B
| – | – |
-1,567
| Closed | -$286K |
|
1070
AstraZeneca
AZN
$263B
| – | – |
-67,132
| Closed | -$12.3M |
|
1071
BigBear.ai
BBAI
$1.41B
| – | – |
-33,855
| Closed | -$183K |
|
1072
Build-A-Bear
BBW
$426M
| – | – |
-6,911
| Closed | -$423K |
|
|
CADE
1073
DELISTED
Cadence Bank
CADE
| – | – |
-195,091
| Closed | -$8.36M |
|
|
CAN
1074
Canaan Creative
CAN
$205M
| – | – |
-18,644
| Closed | -$12.9K |
|
|
CDTX
1075
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-26,492
| Closed | -$5.85M |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.